Primo is a radiopharmaceutical company based in Taiwan. In order to facilitate precision healthcare with molecular imaging in Taiwan, Primo was founded by Prof. Ya-Yao Huang and Dr. Joe Yeh in 2021 with many-year radiopharmaceutical discovery/development experience in Taiwan, especially about clinical introduction and IND submission of new radiopharmaceuticals.
For several years now, our company has been focused on the one-stop clinical development of radiotheranostics in Taiwan, especially form pre-clinical studies, clinical network and regulatory filling to manufacturing , commercialization and distribution activities in Taiwan.
Company Details
- Employees
- 14
- Address
- 14f., No. 167, Dunhua N. Rd., Songshan Dist., Taipei,105,taiwan, Province Of China
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://primobt.com/zh-tw/
- HQ
- Taipei
Primo Biotechnology 普瑞默生技 Questions
Primo Biotechnology 普瑞默生技's website is https://primobt.com/zh-tw/
Primo Biotechnology 普瑞默生技's LinkedIn profile is https://tw.linkedin.com/company/primo-biotechnology
Primo Biotechnology 普瑞默生技 has
14 employees.
View email and phone details for 14
employees at Primo Biotechnology 普瑞默生技.
Primo Biotechnology 普瑞默生技's industry is
Pharmaceutical Manufacturing
Primo Biotechnology 普瑞默生技's top competitors are
Eli Lilly And Company,
Comecer,
Radiopharm Theranostics,
Alpha-9 Oncology,
Ammo Imaging,
Radiomedix, Inc.,
Rayzebio,
Fusion Pharmaceuticals,
Full-Life Technologies,
Cyclotek Pty Ltd.
Primo Biotechnology 普瑞默生技's categories are Pharmaceutical Manufacturing
